Pricing and Reimbursement of Pharmaceuticals in Belgium

被引：0
|
作者：
Lieven Annemans
Ralph Crott
Henri De Clerq
Michel Hyuybrechts
Frank Peys
Hugo Robays
Ingrid Steens
Kathleen Vanschoubroek
Peter Winderickx
机构：
[1] BRI International,
[2] Université Catholique de Louvain,undefined
[3] E.S.S.T.,undefined
[4] Vrije Universiteit Brussel,undefined
[5] Astra Pharmaceuticals Belgium,undefined
[6] Belgian Institute for Health Economics,undefined
[7] University Hospital Gent,undefined
[8] Amgen,undefined
[9] Dworp,undefined
来源：
PharmacoEconomics | 1997年 / 11卷
关键词：
Economic Evaluation; Contingent Valuation; Sickness Fund; Price Setting; Pharmacoeconomic Evaluation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The Belgian healthcare system has a tradition of access and equity at affordable prices. As in other countries, the system becomes pressured by increasing healthcare costs. This paper describes the actual situation in Belgium with special focus on pharmaceutical products and the potential role of pharmacoeconomics in decision making on price and reimbursement.
引用
收藏
页码：203 / 209
页数：6
相关论文
共 50 条
  • [41] EVIDENCE REQUIREMENTS FOR REIMBURSEMENT OF PHARMACEUTICALS ACROSS EUROPE
    Oyebode, Oyinlola
    Garrett, Zoe
    George, Elizabeth
    Cangini, Agnese
    Muscolo, Luisa Anna Adele
    Warren, Simone
    Nemeth, Bertalan
    Foeldesi, Csenge
    Heislerova, Marcela
    Gajdosova, Eva
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2015, 31 (1-2) : 59 - 67
  • [42] THE PRICING OF PHARMACEUTICALS - AN INTERNATIONAL COMPARISON
    DICKSON, M
    CLINICAL THERAPEUTICS, 1992, 14 (04) : 604 - 610
  • [43] Generic entry and the pricing of pharmaceuticals
    Frank, RG
    Salkever, DS
    JOURNAL OF ECONOMICS & MANAGEMENT STRATEGY, 1997, 6 (01) : 75 - 90
  • [44] Strategic pricing of new pharmaceuticals
    Lu, ZJ
    Comanor, WS
    REVIEW OF ECONOMICS AND STATISTICS, 1998, 80 (01) : 108 - 118
  • [45] PRICING AND REIMBURSMENT OF PHARMACEUTICALS IN IRAN
    Moradi, M.
    VALUE IN HEALTH, 2013, 16 (07) : A474 - A475
  • [46] Pharmaceutical pricing and reimbursement reforms in Greece
    Yfantopoulos, John
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2008, 9 (01): : 87 - 97
  • [47] Pricing and reimbursement of orphan drugs in Italy
    Lopatriello, S.
    Schivazappa, C.
    Negrini, C.
    Berto, P.
    VALUE IN HEALTH, 2006, 9 (06) : A208 - A209
  • [48] PRICING AND REIMBURSEMENT POLICY UPDATES IN ASIA
    Paranjoy, S.
    Kaushik, P.
    Kaur, S.
    Sharma, S.
    Sehgal, M.
    VALUE IN HEALTH, 2014, 17 (07) : A788 - A788
  • [49] Pharmaceutical pricing and reimbursement reforms in Greece
    John Yfantopoulos
    The European Journal of Health Economics, 2008, 9 : 87 - 97
  • [50] PRICING AND REIMBURSEMENT POLICIES OF TURKEY AND UKRAINE
    Atikeler, K.
    Pinizhko, O.
    VALUE IN HEALTH, 2015, 18 (07) : A573 - A573
12345